<DOC>
	<DOCNO>NCT01458041</DOCNO>
	<brief_summary>Monitoring efficacy safety aspect iv . iloprost therapy patient critical limb ischemia record clinical parameter .</brief_summary>
	<brief_title>Iloprost Therapy Patients With Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Patients fulfill internationally define criterion critical limb ischemia ; Patients eligible vascular surgery angioplasty intervention Patients treat iloprost infusion . The treat physician decide iloprost treatment study enrollment . Exclusion criterion accordance Summary Product Characteristics Ilomedin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Critical limb ischaemia</keyword>
	<keyword>Iloprost</keyword>
	<keyword>Quality life</keyword>
	<keyword>Visual analogue scale</keyword>
</DOC>